Stocks News

LAST PRICE
47.8350
TODAY'S CHANGE (%)
Trending Up1.3350 (2.8710%)

Bid / Lots
47.7300/ 8
Ask / Lots
47.9700/ 8
Open / Previous Close
46.5000 / 46.5000
Day Range
Low 46.0200
High 48.2100
52 Week Range
Low 7.7900
High 65.6000
Volume
232,268
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Janux Therapeutics Initiated at Outperform by Leerink Partners, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: JANX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/JANX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 22, 2024 08:20 ET (13:20 GMT)
- Leerink Initiates Janux Therapeutics at Outperform With $79 Price Target, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: JANX
  07:14 AM EST, 11/22/2024 (MT Newswires) -- Janux Therapeutics (JANX) has an average rating of buy and mean price target of $66.10, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks...
Nov 15, 2024
- DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Nov 15, 2024 by Dow Jones
  9:30PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: PBF, VTOL, JANX, BTDR, PI
  
  These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 7 through Nov. 13, 2024. Source: VerityData
- DJ Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors -- Barrons.com, from 8:34PM ET on Friday Nov 15, 2024 by Dow Jones
  8:34PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: PBF, VTOL, JANX, BTDR, PI
  
  These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 7 through Nov. 13, 2024. Source: VerityData
Nov 7, 2024
- DJ Janux Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co., from 3:37PM ET on Thursday Nov 07, 2024 by Dow Jones
  3:37PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: JANX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/JANX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 15:37 ET (20:37 GMT)

Yesterday
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 19 hours ago by Dow Jones
  19 hours ago by Dow Jones
  Companies Mentioned: GERN
Nov 15, 2024
- Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:15PM ET on Friday Nov 15, 2024 by Dow Jones
  4:15PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: SRRK
- DJ Centessa Pharmaceuticals Is Maintained at Buy by Guggenheim, from 2:13PM ET on Friday Nov 15, 2024 by Dow Jones
  2:13PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: CNTA
Nov 14, 2024
- Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon, from 8:00AM ET on Thursday Nov 14, 2024 by PR Newswire
  8:00AM ET on Thursday Nov 14, 2024 by PR Newswire
  Companies Mentioned: IOVA, ONCY, SWTX, IBRX, SNDX
- Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon, from 8:00AM ET on Thursday Nov 14, 2024 by CNW Group
  8:00AM ET on Thursday Nov 14, 2024 by CNW Group
  Companies Mentioned: IOVA, ONCY, SWTX, IBRX, SNDX
Nov 13, 2024
- Morgan Stanley Lifts Price Target on Centessa Pharmaceuticals to $27 From $26, Keeps Overweight Rating, from 6:43AM ET on Wednesday Nov 13, 2024 by MT Newswires
  6:43AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: CNTA
Nov 12, 2024
- DJ Scholar Rock Holding Is Maintained at Buy by HC Wainwright & Co., from 12:40PM ET on Tuesday Nov 12, 2024 by Dow Jones
  12:40PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: SRRK
- Wedbush Raises Price Target on Scholar Rock to $40 From $37, Maintains Outperform Rating, from 9:38AM ET on Tuesday Nov 12, 2024 by MT Newswires
  9:38AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: SRRK
- Centessa Pharmaceuticals' Q3 Loss Widens, from 8:49AM ET on Tuesday Nov 12, 2024 by MT Newswires
  8:49AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: CNTA
- Scholar Rock Holding Q3 Net Loss Widens, from 8:02AM ET on Tuesday Nov 12, 2024 by MT Newswires
  8:02AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: SRRK

Janux Therapeutics Inc
NASDAQ:JANXUnited States

Search Criteria

Today

DJ Janux Therapeutics Initiated at Outperform by Leerink Partners, from 3 hours ago by Dow Jones

Leerink Initiates Janux Therapeutics at Outperform With $79 Price Target, from 4 hours ago by MT Newswires

Nov 15, 2024

DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Nov 15, 2024 by Dow Jones

DJ Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors -- Barrons.com, from 8:34PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 7, 2024

DJ Janux Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co., from 3:37PM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Yesterday

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 19 hours ago by Dow Jones

Nov 15, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:15PM ET on Friday Nov 15, 2024 by Dow Jones

DJ Centessa Pharmaceuticals Is Maintained at Buy by Guggenheim, from 2:13PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon, from 8:00AM ET on Thursday Nov 14, 2024 by PR Newswire

Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon, from 8:00AM ET on Thursday Nov 14, 2024 by CNW Group

Nov 13, 2024

Morgan Stanley Lifts Price Target on Centessa Pharmaceuticals to $27 From $26, Keeps Overweight Rating, from 6:43AM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 12, 2024

DJ Scholar Rock Holding Is Maintained at Buy by HC Wainwright & Co., from 12:40PM ET on Tuesday Nov 12, 2024 by Dow Jones

Wedbush Raises Price Target on Scholar Rock to $40 From $37, Maintains Outperform Rating, from 9:38AM ET on Tuesday Nov 12, 2024 by MT Newswires

Centessa Pharmaceuticals' Q3 Loss Widens, from 8:49AM ET on Tuesday Nov 12, 2024 by MT Newswires

Scholar Rock Holding Q3 Net Loss Widens, from 8:02AM ET on Tuesday Nov 12, 2024 by MT Newswires